Evidence map›Paper›PMID 33022754›Full record

ReviewJournal of surgical oncology2021

Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists.

Dario Callegaro, Chandrajit P Raut, Emily Z Keung, Teresa Kim, Cecile Le Pechoux, Javier Martin-Broto, Alessandro Gronchi, Carol Swallow, Rebecca Gladdy

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 5 countries.

Dario CallegaroDepartment of Surgery, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-3392-4002
Chandrajit P RautDepartment of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0001-7297-3221
Emily Z KeungDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID http://orcid.org/0000-0002-8783-8484
Teresa KimDepartment of Surgery, University of Washington, Seattle, Washington, USA.
Cecile Le PechouxDepartment of Radiation Oncology, Gustave Roussy, Villejuif, France.
Javier Martin-BrotoMedical Oncology Department in University Hospital Virgen del Rocio and Institute of Biomedicine of Sevilla (IBIS) (HUVR, CSIC), University of Sevilla, Sevilla, Spain.
Alessandro GronchiDepartment of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Carol SwallowDepartment of Surgery, University of Toronto, Toronto, ON, Canada.
Rebecca GladdyDepartment of Surgery, University of Toronto, Toronto, ON, Canada.
University of Toronto · CABrigham and Women's Hospital · USFondazione IRCCS Istituto Nazionale dei Tumori · ITInstitut Gustave Roussy · FRInstituto de Biomedicina de Sevilla · ESThe University of Texas MD Anderson Cancer Center · USUniversity of Washington · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

The coronavirus disease-2019 (COVID-19) pandemic is deeply impacting the accessibility of cancer patients to surgery. In resource-limited conditions, the standard of care might not be deliverable, but evidence to support alternative management strategies often exists. By revisiting available treatment options, this review provides surgical oncologists with an evidence-based framework for treating patients with gastrointestinal stromal tumor, extremity/truncal soft tissue sarcoma, and retroperitoneal sarcoma to rapidly adapt their decision-making to the constant evolution of the COVID-19 pandemic.

Indexed as

Practice Guidelines as TopicSARS-CoV-2COVID-19Gastrointestinal Stromal TumorsHealth ResourcesHumansImatinib MesylateOncologistsSoft Tissue NeoplasmsSurgical OncologyImatinib MesylateCOVID-19gastrointestinal stromal tumorretroperitoneal sarcomasarcomasoft tissue sarcoma

Identifiers

PMID33022754
PMCPMC7675701
OpenAlexW3089904187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.